SCHEMBL6796515

SCHEMBL6796515

O=C1c2ccccc2C(O)(O)C12Cc1ccccc1C2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.56
HSP90AA1 P07900 1/20 0.56
HSP90AB1 P08238 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
CA7 P43166 1/20 0.41
RECQL P46063 1/20 0.41
BACE1 P56817 1/20 0.41
CA9 Q16790 1/20 0.41
EHMT2 Q96KQ7 1/20 0.41
CYP2D6 P10635 1/20 0.38
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6796508 0.88 ALDH1A1 (0.46) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL31096283 0.76 ALDH1A1 (0.44) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL8371904 0.72 ALDH1A1 (1.00) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL15032487 0.72 ALDH1A1 (1.00) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL3994729 0.67 L3MBTL1 (0.50) ALDH1A1HSP90AA1HSP90AB1L3MBTL1CA1
SCHEMBL6806743 0.67 L3MBTL1 (0.40) ALDH1A1L3MBTL1CYP2D6HTTLMNA
SCHEMBL25698875 0.66 ALDH1A1 (0.53) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL21030440 0.65 TDP2 (0.50) ALDH1A1HSP90AA1HSP90AB1SMN1; SMN2L3MBTL1
SCHEMBL27556275 0.65 PDK2 (0.50) TDP1THRBPOLB
SCHEMBL27818364 0.64 THRB (0.40) ALDH1A1HSP90AA1HSP90AB1L3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082642-A1 Novel estrogen receptor ligands and method III MERCK & CO., INC. 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082642-A1 Novel estrogen receptor ligands and method III ESRRA, ESRRB, FSHR ALDH1A1 1752/4885HSP90AA1 2081/4885HSP90AB1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.